Nine friend-of-the-court briefs have been filed in the nation’s highest court urging rejection of an appeals court’s decision last year that upheld a huge cut in 340B hospitals’ Medicare reimbursement for physician administered drugs.
Thirty-seven state and regional hospital associations last Friday asked the U.S. Supreme Court to reverse the U.S. Court of Appeals for the District of Columbia Circuit’s July 2020 decision upholding the Centers for Medicare & Medicaid Services (CMS’s) nearly 30 percent reduction in Medicare Part B reimbursement for hospitals’ 340B-purchased drugs.
Nine friend-of-the-court briefs have been filed in the nation’s highest court urging rejection of an appeals court’s decision last year that upheld a huge cut in 340B hospitals’ Medicare reimbursement for physician administered drugs.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
